# US 2021/0060338 A1 · Treatment of congestive heart failure with electrical stimulation, and associated systems and methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0060338 A1
- Document ID: US20210060338A1
- Status: Published application
- Kind: A1
- Application number: 17/030,349
- Filed: 2020-09-23
- Published: 2021-03-04
- Earliest claimed: 2016-01-25
- Assignees: Nevro Corporation
- Applicants: Nevro Corp.
- Inventors: James R. Thacker; Kerry Bradley
- Web page: https://patentgrep.com/patent/US20210060338A1

## CPC

- A61N 1/3627: {for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy}
- A61N 1/36114: {Cardiac control, e.g. by vagal stimulation (stimulating the heart A61N1/362)}
- A61N 1/36139: {with automatic adjustment}
- A61N 1/36171: {Frequency}
- A61N 1/056: {Transvascular endocardial electrode systems}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

Systems and methods for treating congestive heart failure with high frequency stimulation are disclosed. A representative method for treating a patient includes applying an electrical signal having a frequency of from about 1 kHz to about 100 kHz to the patient via a treatment system that includes a signal delivery element in electrical communication with the patient's vagus nerve at a portion of the vagus nerve located at or proximate to the anterior interventricular junction of the patient's heart. The method can further include automatically detecting at least one physiological parameter of the patient, automatically determining at least one of an ejection fraction of the patient's heart and a correlate of the ejection fraction based on the detected parameter, and automatically adjusting the applied signal based on the determined ejection fraction.

## Claims

### Claim at position 1

1-22. (canceled)

### Claim 23

A method for treating congestive heart failure in a patient, comprising:
applying an electrical signal to the patient via a treatment system to excite neural tissue proximate and/or within an epicardial fat pad of the patient's heart, wherein the treatment system includes a signal delivery element positioned at the epicardial fat pad of the patient's heart, the electrical signal having a frequency in a range of from about 1 kHz to about 100 kHz;
automatically detecting at least one physiological parameter of the patient via one or more sensing elements;
based on the detected parameter, automatically determining an ejection fraction indicator that is at least one of an ejection fraction of the patient's heart and a correlate of the ejection fraction; and
automatically adjusting the applied signal based on the determined ejection fraction indicator.

### Claim 24 (depends on 23)

The method of claim 23 wherein automatically adjusting the applied signal includes stopping the application of the applied signal in response to detecting an ejection fraction indicator greater than or equal to a target ejection fraction threshold.

### Claim 25 (depends on 23)

The method of claim 23 wherein applying the electrical signal occurs at a first time, and wherein automatically adjusting the applied signal includes applying the electrical signal at a second time in response to detecting an ejection fraction indicator less than the target ejection fraction threshold.

### Claim 26 (depends on 23)

The method of claim 23 wherein automatically adjusting the applied signal includes increasing at least one of an amplitude of the applied signal and a pulse width of the applied signal in response to detecting an ejection fraction indicator less than a target ejection fraction threshold.

### Claim 27 (depends on 23)

The method of claim 23 wherein automatically adjusting the applied signal includes decreasing at least one of an amplitude of the applied signal and a pulse width of the applied signal in response to detecting an ejection fraction indicator greater than or equal to a target ejection fraction threshold.

### Claim 28 (depends on 23)

The method of claim 23 wherein:
automatically detecting a physiological parameter includes automatically detecting the patient's heart rate; and
automatically adjusting the applied signal includes increasing at least one of an amplitude of the applied signal and a pulse width of the applied signal in response to the increase in the patient's heart rate.

### Claim 29 (depends on 23)

The method of claim 23 wherein applying the electrical signal includes applying the signal to the patient via a lead positioned at or proximate to the atrial-ventricular fat pads of the patient's heart.

### Claim 30 (depends on 23)

The method of claim 23 wherein applying the electrical signal includes applying the signal with a pulse width less than or equal to 1/(2×the frequency of the signal).

### Claim 31 (depends on 23)

The method of claim 23 wherein the treatment system includes an implantable treatment system.

### Claim 32 (depends on 23)

The method of claim 23 wherein the at least one detected physiological parameter includes at least one of the patient's heart rate, the patient's blood pressure, and the patient's blood flow rate.

### Claim at position 12

33-48. (canceled)

### Claim 49

A method for treating congestive heart failure in a patient, comprising:
applying an electrical signal to the patient via a treatment system to increase a contraction strength of a left ventricle and/or a right ventricle of the patient's heart, wherein the treatment system includes a signal delivery element positioned at an epicardial fat pad of the patient's heart, and wherein the electrical signal has a frequency in a range of from about 1 kHz to about 100 kHz;
automatically detecting at least one physiological parameter of the patient via one or more sensing elements;
based on the detected parameter, automatically determining an ejection fraction indicator that is at least one of an ejection fraction of the patient's heart and a correlate of the ejection fraction; and
automatically adjusting the applied signal based on the determined ejection fraction indicator.

### Claim 50 (depends on 49)

The method of claim 49 wherein applying the electric signal increases the contraction strength of the left ventricle.

### Claim 51 (depends on 49)

The method of claim 49 wherein applying the electric signal increases the contraction strength of the right ventricle.

### Claim 52 (depends on 49)

The method of claim 49 wherein automatically adjusting the applied signal includes stopping the application of the applied signal in response to detecting an ejection fraction indicator greater than or equal to a target ejection fraction threshold.

### Claim 53 (depends on 49)

The method of claim 49 wherein applying the electrical signal occurs at a first time, and wherein automatically adjusting the applied signal includes applying the electrical signal at a second time in response to detecting an ejection fraction indicator less than the target ejection fraction threshold.

### Claim 54 (depends on 49)

The method of claim 49 wherein automatically adjusting the applied signal includes increasing at least one of an amplitude of the applied signal and a pulse width of the applied signal in response to detecting an ejection fraction indicator less than a target ejection fraction threshold.

### Claim 55 (depends on 49)

The method of claim 49 wherein automatically adjusting the applied signal includes decreasing at least one of an amplitude of the applied signal and a pulse width of the applied signal in response to detecting an ejection fraction indicator greater than or equal to a target ejection fraction threshold.

### Claim 56 (depends on 49)

The method of claim 49 wherein:
automatically detecting a physiological parameter includes automatically detecting the patient's heart rate; and
automatically adjusting the applied signal includes increasing at least one of an amplitude of the applied signal and a pulse width of the applied signal in response to the increase in the patient's heart rate.

### Claim 57 (depends on 49)

The method of claim 49 wherein applying the electrical signal includes applying the signal to the patient via a lead positioned at or proximate to the atrial-ventricular fat pads of the patient's heart.

### Claim 58 (depends on 49)

The method of claim 49 wherein applying the electrical signal includes applying the signal with a pulse width less than or equal to 1/(2×the frequency of the signal).

### Claim 59 (depends on 49)

The method of claim 49 wherein the treatment system includes an implantable treatment system.

### Claim 60 (depends on 49)

The method of claim 49 wherein the at least one detected physiological parameter includes at least one of the patient's heart rate, the patient's blood pressure, and the patient's blood flow rate.
